Micron Technology, Inc.
MU NASDAQ Earnings in 31 daysThere isn't enough steady cash-flow history to value Micron Technology yet. Its growth outlook scores strong; the balance sheet is solid.
No single event this week: analyst targets span ~₹33.5K–278.0K a share.
On consensus MU is the cheapest of its peers, at ~3.4x next year's earnings. Otto can't build a cash-flow range for this one yet, so the range shown is the analysts' own; the price, ₹66.0K, sits inside it.
01 · Forward P/E
- MU ~3.4x
- AMD ~29x
- AVGO ~17.6x
- INTC ~31x
Next fiscal year's consensus earnings. P/E ÷ growth: MU ~0.02, peers ~0.10–0.12.
02 · Latest event
No results, sharp move or standout headline in the last week.
03 · The range, a share
- Analyst targets ~₹33.5K–278.0K
Current price ₹66.0K.
- ~3.4x
- Forward P/E, consensus
- ~0.02
- P/E per point of EPS growth
- ₹66.0K
- Price: inside the target range
- ~₹33.5K–278.0K
- Analyst target range
Forward P/E and analyst targets: Yahoo Finance consensus. No cash-flow range: the company's reported cash flows don't support one yet. Not investment advice — Otto just crunches numbers.
At a glance
tap a tile to dig inOtto's verdict
the tiles above, in a line each- Health 18 of 20 health checks pass.
- Growth Revenue trend ≈ +15%/yr (extended trend, not a forecast).
- Street Analysts lean strong buy · avg target +119% from here.
- Dividend Pays a dividend — yields 0.08%.
- Insiders Insiders, last 12 months: 0 buys · 3 sells.
Not investment advice — Otto just crunches numbers.
Price trend
-32.2% over the last month · S&P 500 -9.4%
What think
The market's move: -32.2% over the past year
Trading 49% up its 52-week range. Price is the market's live vote — not advice.
Analyst consensus: Strong Buy · 45 analysts
Average 12-month target ₹144,742.30 — +119.2% vs today.
Yahoo Finance's analyst aggregate. Sentiment, not advice.
Insiders: 0 buys · 3 sales in recent filings
Open-market trades from SEC Form 4. Sales are often pre-planned (10b5-1); buys tend to say more. Sentiment, not advice.
InvestRight readers: 0 watching
This site's own activity — not a broad measure. Sentiment, not advice.
The snowflake
checks passed on each axis- Value 0/— checks
- Future 4/4 checks
- Past 4/4 checks
- Health 6/6 checks
- Dividend 4/6 checks
What does this show?
Five quick health scores — Value, Future, Past, Health and Dividend — each 0–100%. A bigger, more even shape means a stock that scores well across the board; a spiky one is strong on some axes and weak on others.
Learn more on Investopedia →Fair value
our estimate · not analyst forecastNot enough steady cash-flow history to estimate a fair value for MU yet.
What does this show?
Our estimate of what one share is worth based on the cash the business is expected to generate (a discounted-cash-flow model), next to today's price. Below fair value hints undervalued, above hints expensive — it's an estimate, not a guarantee.
Learn more on Investopedia →Health checks
20 checks run on free data- ⚠ Yield beats the market yield 0.08% vs market ~1.5%
- ⚠ Yield in the top quartile of payers yield 0.08% vs 2.26% cut among the 101 payers Otto tracks
- ✓ Debt/equity falling over time long-term debt/equity 2.0% vs 15.8%
- ✓ Debt is under 40% of equity debt/equity 4%
- ✓ Debt well covered by cash flow operating cash flow covers 2731.0% of debt
- ✓ Dividend covered by earnings and cash flow covered by both earnings and free cash flow
Show all 20 checks by axis
Value 0/— passed
- – Trading below our fair-value estimate
- – P/B below industry industry P/B not on the free feed
- – P/E below industry industry P/E not on the free feed
- – P/E below peer average peer P/Es land after the next refresh
- – P/S sane vs its own history needs multi-year P/S (Tier B)
- – More than 20% below fair value
Future 4/4 passed
- ✓ Earnings trending up 36.7%/yr over 9yr
- – Growth beats the industry industry growth not on the free feed
- ✓ Earnings growth beats the market 36.7%/yr vs market ~9.0%
- ✓ Revenue trending up 23.2%/yr over 9yr
- ✓ Return on equity improving ROE 61.4% vs 27.3% 9yr ago
Past 4/4 passed
- ✓ Earnings grew over the period 5.1B → 85.0B
- – High-quality earnings (few one-offs) one-off detection deferred — needs statement detail
- ✓ Growth accelerating vs its average latest 895.1%/yr vs 36.7% average
- ✓ Revenue higher than five years ago 20.3B → 133.2B
- ✓ Return on equity above 20% ROE 88.3%
Health 6/6 passed
- ✓ Debt/equity falling over time long-term debt/equity 2.0% vs 15.8%
- ✓ Debt is under 40% of equity debt/equity 4%
- ✓ Debt well covered by cash flow operating cash flow covers 2731.0% of debt
- ✓ Interest comfortably covered by profit EBIT covers interest 937.2×
- ✓ Short-term assets cover long-term debt 91.1B vs 30.0B
- ✓ Short-term assets cover short-term bills 91.1B vs 27.5B
Dividend 4/6 passed
- ✓ Dividend covered by earnings and cash flow covered by both earnings and free cash flow
- ✓ Dividend growing over time over 7yr on record
- ✓ No dividend cut in recent years steady over 7yr on record
- ✓ Payout ratio under 75% payout 0.7% of earnings
- ⚠ Yield beats the market yield 0.08% vs market ~1.5%
- ⚠ Yield in the top quartile of payers yield 0.08% vs 2.26% cut among the 101 payers Otto tracks
What does this show?
Pass/fail rules on the company's finances — debt levels, profitability, cash cover and so on. More greens means a sturdier balance sheet; an n/a just means we didn't have that data point.
Learn more on Investopedia →Past performance
10-yr history from SEC EDGAR filingsRevenue
Earnings
Free cash flow
dashed line = what it'd look like growing at our ~9% market-average benchmark, for comparison
What does this show?
How revenue, earnings and free cash flow have grown over the years. Bars rising left-to-right show a growing business; the dashed line is a market-average pace for comparison.
Learn more on Investopedia →Revenue & expenses
FY 2026What does this show?
How a company turns sales into profit. Revenue splits into the direct cost of sales and the gross profit left over; from that gross profit come operating costs (R&D, SG&A), tax and interest — what survives is net income. Every figure is also shown as a share of revenue, so you can compare periods and companies of different sizes.
Learn more on Investopedia →Future
trend, not analyst forecastRevenue · extended at 15.0%/yr
Earnings · extended at 15.0%/yr
Dashed bars just extend the historical trend (capped at ±15%/yr) — the same growth our DCF uses. It's arithmetic on the past, not an analyst forecast; real futures bend.
What does this show?
Solid bars are history; dashed bars simply extend the past growth trend a few years forward — capped so it stays sane. It's a trend line, not an analyst forecast.
Learn more on Investopedia →Dividend
from cash actually paid, not promisesTotal dividends paid · split-proof, unlike per-share history
What does this show?
The share of profit paid back to shareholders as cash. Yield is that cash as a % of the price; the payout gauge shows how much of earnings is paid out (over ~75% can be hard to sustain).
Learn more on Investopedia →Ownership & insiders
from SEC Form 4 filings0 open-market buys · 3 sales in the last 10 saved filings
- Sell Deboer Scott J · Pres. & Chief Tech & Prod Offr 28,545 sh · ₹2.38B 2026-10-16
- Sell Ray Michael Charles · SVP, Chief Legal Officer 40 sh · ₹3.51M 2026-10-14
- Sell Ray Michael Charles · SVP, Chief Legal Officer 6,288 sh · ₹541.71M 2026-10-14
- Award Mehrotra Sanjay · President and CEO 21,233 sh 2026-10-13
- Tax-withhold Mehrotra Sanjay · President and CEO 166,256 sh · ₹15.24B 2026-10-13
- Exercise Mehrotra Sanjay · President and CEO 235,666 sh 2026-10-13
- Award Ray Michael Charles · SVP, Chief Legal Officer 4,298 sh 2026-10-13
- Tax-withhold Ray Michael Charles · SVP, Chief Legal Officer 8,989 sh · ₹823.88M 2026-10-13
- Award Murphy Mark J. · EVP & Chief Financial Officer 7,078 sh 2026-10-13
- Tax-withhold Murphy Mark J. · EVP & Chief Financial Officer 50,343 sh · ₹4.61B 2026-10-13
Insiders must report within two business days. Sales are often pre-planned (10b5-1) rather than a signal — buys tend to say more.
What does this show?
Buys and sells by the company's own directors and officers, from their SEC filings. Insiders sell for many reasons, but clusters of open-market buying can signal confidence.
Learn more on Investopedia →Spot a missing competitor? Sign in to add it — it'll show for everyone.
What does this show?
A few peers in the same business, each with its own mini snowflake, so you can see how this company stacks up rather than judging it in isolation. Anyone signed in can add a missing competitor — it shows for everyone, marked as user-added.
Learn more on Investopedia →Leadership
Yahoo Finance · photos & bios via Wikidata-
Dr. Scott J. DeBoer Ph.D.
President & Chief Technology and Products Officer
- Age
- 59
- Total yearly comp
- ₹182.99M
-
Mr. Michael Charles Ray Ph.D.
Senior VP, Chief Legal Officer & Corporate Secretary
- Age
- 57
Ranked by title — reporting lines aren't public data. Compensation is the total Yahoo reports; blank means it isn't disclosed there.
In the news
- Dow Jones Futures: AMD, Nvidia, Micron Lead AI Trade Lower With Nvidia Earnings On Deck
- S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
- 4 Chip Stocks Down as Much as 36% From Their Highs to Buy and Hold for the Next Decade
- Stocks to Watch Recap: Robinhood, Nvidia, SpaceX, L3Harris
- David Tepper's Top Q3 2026 Move: Space Exploration Technologies Corp at a 6.93% Portfolio Impact
- 5 Unstoppable Stocks to Buy According to Analysts
- Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again
- AI Stocks Resume Their Slide
My notes
Sign in to keep a private decision journal on this stock — only you can see your notes.
Hi! I can explain Micron's numbers — valuation, health, the dividend, the fair-value gap. What would you like to know?
Otto explains what's on this page — not investment advice.